G8 and G9 Rotavirus A genotypes were reported for the first time in Gabon.
Gabonrotavirusobservé April 2018 to November 2019publié 2021EBioMedicineOpenAlexdocument de 5 observationsDOI 10.1016/j.ebiom.2021.103648
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
3 256 evidences · page 100 / 131
G8 and G9 Rotavirus A genotypes were reported for the first time in Gabon.
Gabonrotavirusobservé April 2018 to November 2019publié 2021EBioMedicineOpenAlexdocument de 5 observationsDOI 10.1016/j.ebiom.2021.103648
23,9 %Streptococcus B was associated with aerobic vaginitis in 23.9% of cases.
Gabonaerobic vaginitispublié 2022International Journal of Women s HealthOpenAlexdocument de 19 observationsDOI 10.2147/ijwh.s349754
20 %Using the Spatial Durbin Error Model (SDEM), the relationship between the prevalence and insecticide-treated bed nets (ITNs) coverage was decreasing after 20% of coverage.
Gabonpaludismepublié 2024Malaria journalPubMeddocument de 5 observations
5,1 %Filaria infection prevalence was 5.1% among school-aged children in Gabon.
Gabonfilariaobservé 2021publié 2024Tropical medicine and infectious diseaseeurope_pmcdocument de 8 observationsDOI 10.3390/tropicalmed10010011
306 patients306 patients were diagnosed with type 1 diabetes during the study period (2010–2017) and followed-up in the Endocrinology Department at CHUL.
Gabondiabète de type 1observé 2010–2017publié 2019International journal of pediatrics & adolescent medicinePubMeddocument de 7 observations
23,8 %Among HIV-positive individuals aged 0–24 years in Gabon, viral suppression rates were 23.8% in the 0–7 years age group, 29.2% in the 8–15 years age group, and 42.6% in the 16–24 years age group.
GabonVIH/sidapublié 2026PathogensOpenAlexdocument de 6 observationsDOI 10.3390/pathogens15050502
1,5 %Insufficient calcium levels were found in 1.5% of newborns in a prospective cross-sectional study of pregnant women in Lambaréné, Gabon.
Gaboncalcium deficiencypublié 2024Scientific reportseurope_pmcdocument de 8 observations
500 nMIvermectin showed activity against stage IV/V gametocytes of the malaria parasite with a 50% inhibitory concentration of 500 nM.
Gabonpaludismepublié 2019Antimicrobial agents and chemotherapyPubMeddocument de 2 observations
22 casesA total of 22 severe cases of Plasmodium ovale malaria were published, out of which five were fatal.
GabonPlasmodium ovale malariapublié 2017Malaria journalPubMeddocument de 4 observations
10 participantsTwelve weeks following immunization, 10 out of 13 participants in the vaccine group were sterilely protected against heterologous controlled human malaria infection (CHMI) using the Pf7G8 strain.
Gabonpaludismepublié 2021Nature communicationsPubMeddocument de 4 observations
2,8 %La prévalence de Plasmodium malariae était de 2,8 % dans l'échantillon de 257 enfants.
GabonpaludismeHAL · Unilimdocument de 81 observations
4,8 %Mansonella perstans was detected in 61 out of 1,258 febrile children, corresponding to a prevalence of 4.8%.
Gabonloasepublié 2015PLoS neglected tropical diseasesOpenAlexdocument de 15 observationsDOI 10.1371/journal.pntd.0004155
65 %A treatment-emerging mutation in the Pfatp4 gene, G358S, was detected in 65% of treatment failures.
Gabonpaludismepublié 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 4 observations
60 %Methylene blue inhibited adult worms by 60% in mice infected with S. mansoni.
Gabonschistosomiasepublié 2021PLoS neglected tropical diseaseseurope_pmcdocument de 5 observationsDOI 10.1371/journal.pntd.0009511
8,8 %Lastourville accounted for 8.8% of severe malaria cases in southeastern Gabon in 2019.
Gabonpaludismeobservé 2019publié 2023BMC infectious diseaseseurope_pmcdocument de 14 observations
0,98 AUCSh-TSP-2 had an area under the curve of 0.98 in serum for diagnosing Schistosoma haematobium infection.
Gabonschistosomiasepublié 2021The Lancet. Microbeeurope_pmcdocument de 7 observationsDOI 10.1016/s2666-5247(21)00150-6
1,2 aORIndividuals with anti-Plasmodium IgG levels > 85 μg/ml had an aOR of 1.20 (95% CI: 0.36, 3.92, P = 0.760) for having spleen parenchymal lesions.
Gabonspleen parenchymal lesionsHAL · Unilimdocument de 153 observations
74 %In adults, 74% to 100% of individuals who received a vaccine dose of 3 × 10⁴, 3 × 10⁵, 3 × 10⁶, or 2 × 10⁷ PFU had a ≥4.0-fold increase in geometric mean titres of Zaire Ebola virus glycoprotein-specific antibodies at day 28.
Gabonmaladie à virus Ebolapublié 2017PLoS medicineeurope_pmcdocument de 17 observations
2,16 infectionsThe mean number of sexually transmitted infections was 2.16 (standard deviation 1.35) in HIV-positive pregnant women.
Gabonsexually transmitted infections · VIH/sidapublié 2023Infectious diseases of povertyPubMeddocument de 7 observations
27,7 %27.7% of the total population produced both anti-SARS-CoV-2 N-protein antibodies and anti-SARS-CoV-2 S-protein antibodies.
GabonCOVID-19publié 2021BMC Research NotesOpenAlexdocument de 7 observationsDOI 10.1186/s13104-021-05570-3
50 %Neutralising antibodies were detected in more than 50% of participants at vaccine doses ≥3 × 10⁵ PFU.
Gabonmaladie à virus Ebolapublié 2017PLoS medicineeurope_pmcdocument de 17 observations
1,74 %The seroprevalence of hepatitis B virus (HBV) infection was 1.74% among haemodialysis patients at the Franceville haemodialysis centre in Gabon.
Gabonhépatite Bpublié 2025Ghana medical journalPubMeddocument de 5 observations
53,9 %Among bacterial vaginosis positive patients, 53.90% (249/462) were non-pregnant but capable of bearing children.
Gabonvaginose bactériennepublié 2022Microbial pathogenesiseurope_pmcdocument de 16 observations
73,4 %Of 417 severe malaria cases, 94 (73.4%) were adolescents in 2021.
Gabonpaludismeobservé 2021publié 2024International Journal of Contemporary PediatricsOpenAlexdocument de 10 observationsDOI 10.18203/2349-3291.ijcp20241286
Children aged 0–9 years had the lowest SARS-CoV-2 seroprevalence in Africa.
GabonCOVID-19publié 2022BMJ global healtheurope_pmcdocument de 4 observationsDOI 10.1136/bmjgh-2022-008793
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.